Strides operates in development and manufacturing of pharmaceutical products and has emerged as one of the world's leading producers of soft gelatin capsules. The company has followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure. The company balances portfolio growth with manufacturing excellence across regulated and emerging markets.
Cyborg Score Rationale
The company's consolidated net profit jumped 81.98% to Rs 131.52 crore on a 4.62% increase in revenue from operations to Rs 1,220.83 crore in Q2 Sept 2025. Recent margin expansion and strategic CEO appointments demonstrate operational momentum, though modest revenue growth and inorganic strategy suggest moderate organic capabilities.
Top Insights
Gross margin expanded sharply to 61.2% (280 bps YoY) and EBITDA increased 12.2% YoY to Rs 235.9 crore in Q3 FY26 while EBITDA margin improved to 19.8% (160 bps YoY).
Ex-US market revenue stood at $64 million with strong 20% YoY growth, driven by other regulated markets and growth markets offsetting weak institutional demand and flat US performance.
Strides Pharma's subsidiary Arco Lab completed acquisition of Neviton Softech for €2M (~₹21.8 Cr) to enhance digital capabilities.
The company has delivered a poor sales growth of 10.6% over past five years.
Named Competitors
Generics & Specialty Pharma — Indian multinational generic pharmaceutical manufacturer
Niche Generics — Global generic pharma company with specialty formulations
Specialty Generics — Indian pharma manufacturer with global regulatory presence
Recent Developments
(February 2026) Arco Lab acquisition of Neviton Softech completed to boost digital capabilities
(January 2026) Puneet Kumar Malik stepped down as Senior Management Personnel
(December 2025) FDA inspection at Chestnut Ridge facility completed with Form 483 observations
(Q2 FY26) Net profit surged 82% YoY with margin expansion across gross and EBITDA metrics
Open the full interactive Strides Pharma Science Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.